Neurotrophin-3 and tyrosine kinase C have modulatory effects on neuropathic pain in the rat dorsal root ganglia

Gabriel C. Tender, Alan David Kaye, Yuan Yuan Li, Jian Guo Cui

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

BACKGROUND: Neurotrophin-3 (NT3) and its cognate receptor, tyrosine kinase C (TrkC), have recently been shown to modulate neuropathic pain. Another receptor, the transient receptor potential vanilloid 1, is considered a molecular integrator for nociception. Transient receptor potential vanilloid 1-positive cells can be selectively ablated by Resiniferatoxin (RTX). NT3 changes in the dorsal root ganglia (DRG) after RTX treatment may further define their role in pain modulation. OBJECTIVE: To demonstrate the role of NT3 and TrkC in intraganglial RTX-induced pain suppression and in neuropathic pain development. METHODS: Fifty-three rats underwent a photochemical left sciatic nerve injury. Neuropathic animals were treated by RTX injection in the ipsilateral L3-6 DRG. NT3 and TrkC presence in the DRG was evaluated before and after the nerve injury, as well as after RTX treatment. RESULTS: The RTX injection resulted in pain inhibition. NT3 normally expressed mainly in large- and medium-size neurons. NT3 presence was increased mainly in the small DRG cells of neuropathic animals, and the medium- and large-size neurons of nonallodynic rats. RTX treatment of allodynic rats changed the NT3 distribution to a nonallodynic pattern. TrkC expressed mainly in large/medium-size neurons. After nerve injury, TrkC expression was also increased in the small DRG cells of allodynic animals (although less than NT3), and the medium- and large-size cells of nonallodynic ones. After RTX, TrkC expression gradually decreased, but with persistence in the large DRG cells. CONCLUSION: NT3 may have antinociceptive effects in the DRG. These effects may be mediated, at least in part, by TrkC in the medium- and large-size DRG neurons.

Original languageEnglish
Pages (from-to)1048-1055
Number of pages8
JournalNeurosurgery
Volume68
Issue number4
DOIs
StatePublished - Apr 1 2011

Fingerprint

Neurotrophin 3
Spinal Ganglia
Neuralgia
Protein-Tyrosine Kinases
Neurons
Pain
Wounds and Injuries
3-tyrosine
Injections
Nociception
resiniferatoxin
Receptor Protein-Tyrosine Kinases
Sciatic Nerve
Cell Size
Therapeutics

Keywords

  • Dorsal root ganglia
  • Neuropathic pain
  • Neurotrophin-3
  • Resiniferatoxin
  • Sciatic nerve injury
  • Transient receptor potential vanilloid 1

ASJC Scopus subject areas

  • Clinical Neurology
  • Surgery

Cite this

Neurotrophin-3 and tyrosine kinase C have modulatory effects on neuropathic pain in the rat dorsal root ganglia. / Tender, Gabriel C.; Kaye, Alan David; Li, Yuan Yuan; Cui, Jian Guo.

In: Neurosurgery, Vol. 68, No. 4, 01.04.2011, p. 1048-1055.

Research output: Contribution to journalArticle

Tender, Gabriel C. ; Kaye, Alan David ; Li, Yuan Yuan ; Cui, Jian Guo. / Neurotrophin-3 and tyrosine kinase C have modulatory effects on neuropathic pain in the rat dorsal root ganglia. In: Neurosurgery. 2011 ; Vol. 68, No. 4. pp. 1048-1055.
@article{ccff429498354456b07fe775e6c753be,
title = "Neurotrophin-3 and tyrosine kinase C have modulatory effects on neuropathic pain in the rat dorsal root ganglia",
abstract = "BACKGROUND: Neurotrophin-3 (NT3) and its cognate receptor, tyrosine kinase C (TrkC), have recently been shown to modulate neuropathic pain. Another receptor, the transient receptor potential vanilloid 1, is considered a molecular integrator for nociception. Transient receptor potential vanilloid 1-positive cells can be selectively ablated by Resiniferatoxin (RTX). NT3 changes in the dorsal root ganglia (DRG) after RTX treatment may further define their role in pain modulation. OBJECTIVE: To demonstrate the role of NT3 and TrkC in intraganglial RTX-induced pain suppression and in neuropathic pain development. METHODS: Fifty-three rats underwent a photochemical left sciatic nerve injury. Neuropathic animals were treated by RTX injection in the ipsilateral L3-6 DRG. NT3 and TrkC presence in the DRG was evaluated before and after the nerve injury, as well as after RTX treatment. RESULTS: The RTX injection resulted in pain inhibition. NT3 normally expressed mainly in large- and medium-size neurons. NT3 presence was increased mainly in the small DRG cells of neuropathic animals, and the medium- and large-size neurons of nonallodynic rats. RTX treatment of allodynic rats changed the NT3 distribution to a nonallodynic pattern. TrkC expressed mainly in large/medium-size neurons. After nerve injury, TrkC expression was also increased in the small DRG cells of allodynic animals (although less than NT3), and the medium- and large-size cells of nonallodynic ones. After RTX, TrkC expression gradually decreased, but with persistence in the large DRG cells. CONCLUSION: NT3 may have antinociceptive effects in the DRG. These effects may be mediated, at least in part, by TrkC in the medium- and large-size DRG neurons.",
keywords = "Dorsal root ganglia, Neuropathic pain, Neurotrophin-3, Resiniferatoxin, Sciatic nerve injury, Transient receptor potential vanilloid 1",
author = "Tender, {Gabriel C.} and Kaye, {Alan David} and Li, {Yuan Yuan} and Cui, {Jian Guo}",
year = "2011",
month = "4",
day = "1",
doi = "10.1227/NEU.0b013e318208f9c4",
language = "English",
volume = "68",
pages = "1048--1055",
journal = "Neurosurgery",
issn = "0148-396X",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Neurotrophin-3 and tyrosine kinase C have modulatory effects on neuropathic pain in the rat dorsal root ganglia

AU - Tender, Gabriel C.

AU - Kaye, Alan David

AU - Li, Yuan Yuan

AU - Cui, Jian Guo

PY - 2011/4/1

Y1 - 2011/4/1

N2 - BACKGROUND: Neurotrophin-3 (NT3) and its cognate receptor, tyrosine kinase C (TrkC), have recently been shown to modulate neuropathic pain. Another receptor, the transient receptor potential vanilloid 1, is considered a molecular integrator for nociception. Transient receptor potential vanilloid 1-positive cells can be selectively ablated by Resiniferatoxin (RTX). NT3 changes in the dorsal root ganglia (DRG) after RTX treatment may further define their role in pain modulation. OBJECTIVE: To demonstrate the role of NT3 and TrkC in intraganglial RTX-induced pain suppression and in neuropathic pain development. METHODS: Fifty-three rats underwent a photochemical left sciatic nerve injury. Neuropathic animals were treated by RTX injection in the ipsilateral L3-6 DRG. NT3 and TrkC presence in the DRG was evaluated before and after the nerve injury, as well as after RTX treatment. RESULTS: The RTX injection resulted in pain inhibition. NT3 normally expressed mainly in large- and medium-size neurons. NT3 presence was increased mainly in the small DRG cells of neuropathic animals, and the medium- and large-size neurons of nonallodynic rats. RTX treatment of allodynic rats changed the NT3 distribution to a nonallodynic pattern. TrkC expressed mainly in large/medium-size neurons. After nerve injury, TrkC expression was also increased in the small DRG cells of allodynic animals (although less than NT3), and the medium- and large-size cells of nonallodynic ones. After RTX, TrkC expression gradually decreased, but with persistence in the large DRG cells. CONCLUSION: NT3 may have antinociceptive effects in the DRG. These effects may be mediated, at least in part, by TrkC in the medium- and large-size DRG neurons.

AB - BACKGROUND: Neurotrophin-3 (NT3) and its cognate receptor, tyrosine kinase C (TrkC), have recently been shown to modulate neuropathic pain. Another receptor, the transient receptor potential vanilloid 1, is considered a molecular integrator for nociception. Transient receptor potential vanilloid 1-positive cells can be selectively ablated by Resiniferatoxin (RTX). NT3 changes in the dorsal root ganglia (DRG) after RTX treatment may further define their role in pain modulation. OBJECTIVE: To demonstrate the role of NT3 and TrkC in intraganglial RTX-induced pain suppression and in neuropathic pain development. METHODS: Fifty-three rats underwent a photochemical left sciatic nerve injury. Neuropathic animals were treated by RTX injection in the ipsilateral L3-6 DRG. NT3 and TrkC presence in the DRG was evaluated before and after the nerve injury, as well as after RTX treatment. RESULTS: The RTX injection resulted in pain inhibition. NT3 normally expressed mainly in large- and medium-size neurons. NT3 presence was increased mainly in the small DRG cells of neuropathic animals, and the medium- and large-size neurons of nonallodynic rats. RTX treatment of allodynic rats changed the NT3 distribution to a nonallodynic pattern. TrkC expressed mainly in large/medium-size neurons. After nerve injury, TrkC expression was also increased in the small DRG cells of allodynic animals (although less than NT3), and the medium- and large-size cells of nonallodynic ones. After RTX, TrkC expression gradually decreased, but with persistence in the large DRG cells. CONCLUSION: NT3 may have antinociceptive effects in the DRG. These effects may be mediated, at least in part, by TrkC in the medium- and large-size DRG neurons.

KW - Dorsal root ganglia

KW - Neuropathic pain

KW - Neurotrophin-3

KW - Resiniferatoxin

KW - Sciatic nerve injury

KW - Transient receptor potential vanilloid 1

UR - http://www.scopus.com/inward/record.url?scp=79952897980&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952897980&partnerID=8YFLogxK

U2 - 10.1227/NEU.0b013e318208f9c4

DO - 10.1227/NEU.0b013e318208f9c4

M3 - Article

C2 - 21221027

AN - SCOPUS:79952897980

VL - 68

SP - 1048

EP - 1055

JO - Neurosurgery

JF - Neurosurgery

SN - 0148-396X

IS - 4

ER -